{"id":"https://openalex.org/W2613601474","doi":"https://doi.org/10.1186/s40364-017-0098-3","title":"Clinical significance of intronic variants in BRAF inhibitor resistant melanomas with altered BRAF transcript splicing","display_name":"Clinical significance of intronic variants in BRAF inhibitor resistant melanomas with altered BRAF transcript splicing","alternate_titles":[],"publication_year":2017,"publication_date":"2017-05-08","ids":{"openalex":"https://openalex.org/W2613601474","doi":"https://doi.org/10.1186/s40364-017-0098-3","mag":"2613601474","pmid":"https://pubmed.ncbi.nlm.nih.gov/28503307","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/5426037"},"language":"en","primary_location":{"id":"doi:10.1186/s40364-017-0098-3","doi":"https://doi.org/10.1186/s40364-017-0098-3","is_oa":true,"landing_page_url":"https://doi.org/10.1186/s40364-017-0098-3","pdf_url":"https://link.springer.com/content/pdf/10.1186/s40364-017-0098-3.pdf","source":{"id":"https://openalex.org/S2764853569","display_name":"Biomarker Research","issn_l":"2050-7771","issn":["2050-7771"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","doyens","jufo-1","ki-jl-1","norway-1","oarl","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Biomarker Research","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2613601474"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://link.springer.com/content/pdf/10.1186/s40364-017-0098-3.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5090820450","display_name":"Gulietta M. Pupo","orcid":"https://orcid.org/0000-0002-8556-4002","observed_orcids":["https://orcid.org/0000-0002-8556-4002"]},"institutions":[{"id":"https://openalex.org/I129604602","display_name":"The University of Sydney","ror":"https://ror.org/0384j8v12","country_code":"AU","type":"education","lineage":["https://openalex.org/I129604602"]},{"id":"https://openalex.org/I2803024705","display_name":"Westmead Hospital","ror":"https://ror.org/04gp5yv64","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I2803024705","https://openalex.org/I4405259172"]},{"id":"https://openalex.org/I4210118383","display_name":"Melanoma Institute Australia","ror":"https://ror.org/02jxrhq31","country_code":"AU","type":"nonprofit","lineage":["https://openalex.org/I4210118383"]},{"id":"https://openalex.org/I4210145422","display_name":"Westmead Institute for Medical Research","ror":"https://ror.org/04zj3ra44","country_code":"AU","type":"facility","lineage":["https://openalex.org/I4210145422"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Gulietta M. Pupo","raw_affiliation_strings":["Centre for Cancer Research, The Westmead Millennium Institute for Medical Research, University of Sydney, Westmead Hospital, Westmead, NSW, Australia","Melanoma Institute Australia, Sydney, NSW Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre for Cancer Research, The Westmead Millennium Institute for Medical Research, University of Sydney, Westmead Hospital, Westmead, NSW, Australia","institution_ids":["https://openalex.org/I129604602","https://openalex.org/I2803024705","https://openalex.org/I4210145422"]},{"raw_affiliation_string":"Melanoma Institute Australia, Sydney, NSW Australia","institution_ids":["https://openalex.org/I4210118383"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108665593","display_name":"Suzanah C. Boyd","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210118383","display_name":"Melanoma Institute Australia","ror":"https://ror.org/02jxrhq31","country_code":"AU","type":"nonprofit","lineage":["https://openalex.org/I4210118383"]},{"id":"https://openalex.org/I99043593","display_name":"Macquarie University","ror":"https://ror.org/01sf06y89","country_code":"AU","type":"education","lineage":["https://openalex.org/I99043593"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Suzanah C. Boyd","raw_affiliation_strings":["Faculty of Medicine and Health Sciences, Macquarie University, Sydney, NSW, Australia","Melanoma Institute Australia, Sydney, NSW Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Faculty of Medicine and Health Sciences, Macquarie University, Sydney, NSW, Australia","institution_ids":["https://openalex.org/I99043593"]},{"raw_affiliation_string":"Melanoma Institute Australia, Sydney, NSW Australia","institution_ids":["https://openalex.org/I4210118383"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110092098","display_name":"Carina Fung","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210118383","display_name":"Melanoma Institute Australia","ror":"https://ror.org/02jxrhq31","country_code":"AU","type":"nonprofit","lineage":["https://openalex.org/I4210118383"]},{"id":"https://openalex.org/I99043593","display_name":"Macquarie University","ror":"https://ror.org/01sf06y89","country_code":"AU","type":"education","lineage":["https://openalex.org/I99043593"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Carina Fung","raw_affiliation_strings":["Faculty of Medicine and Health Sciences, Macquarie University, Sydney, NSW, Australia","Melanoma Institute Australia, Sydney, NSW Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Faculty of Medicine and Health Sciences, Macquarie University, Sydney, NSW, Australia","institution_ids":["https://openalex.org/I99043593"]},{"raw_affiliation_string":"Melanoma Institute Australia, Sydney, NSW Australia","institution_ids":["https://openalex.org/I4210118383"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083061830","display_name":"Matteo Salvatore Carlino","orcid":"https://orcid.org/0000-0002-7861-4104","observed_orcids":["https://orcid.org/0000-0002-7861-4104"]},"institutions":[{"id":"https://openalex.org/I129604602","display_name":"The University of Sydney","ror":"https://ror.org/0384j8v12","country_code":"AU","type":"education","lineage":["https://openalex.org/I129604602"]},{"id":"https://openalex.org/I2803024705","display_name":"Westmead Hospital","ror":"https://ror.org/04gp5yv64","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I2803024705","https://openalex.org/I4405259172"]},{"id":"https://openalex.org/I4210118383","display_name":"Melanoma Institute Australia","ror":"https://ror.org/02jxrhq31","country_code":"AU","type":"nonprofit","lineage":["https://openalex.org/I4210118383"]},{"id":"https://openalex.org/I4210145422","display_name":"Westmead Institute for Medical Research","ror":"https://ror.org/04zj3ra44","country_code":"AU","type":"facility","lineage":["https://openalex.org/I4210145422"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Matteo S. Carlino","raw_affiliation_strings":["Centre for Cancer Research, The Westmead Millennium Institute for Medical Research, University of Sydney, Westmead Hospital, Westmead, NSW, Australia","Departments of Medical Oncology, Crown Princess Mary Cancer Centre, Westmead Hospital, Sydney, NSW Australia","Melanoma Institute Australia, Sydney, NSW Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre for Cancer Research, The Westmead Millennium Institute for Medical Research, University of Sydney, Westmead Hospital, Westmead, NSW, Australia","institution_ids":["https://openalex.org/I129604602","https://openalex.org/I2803024705","https://openalex.org/I4210145422"]},{"raw_affiliation_string":"Departments of Medical Oncology, Crown Princess Mary Cancer Centre, Westmead Hospital, Sydney, NSW Australia","institution_ids":["https://openalex.org/I2803024705"]},{"raw_affiliation_string":"Melanoma Institute Australia, Sydney, NSW Australia","institution_ids":["https://openalex.org/I4210118383"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022520811","display_name":"Alexander Maxwell Menzies","orcid":"https://orcid.org/0000-0001-5183-7562","observed_orcids":["https://orcid.org/0000-0001-5183-7562"]},"institutions":[{"id":"https://openalex.org/I129604602","display_name":"The University of Sydney","ror":"https://ror.org/0384j8v12","country_code":"AU","type":"education","lineage":["https://openalex.org/I129604602"]},{"id":"https://openalex.org/I4210118383","display_name":"Melanoma Institute Australia","ror":"https://ror.org/02jxrhq31","country_code":"AU","type":"nonprofit","lineage":["https://openalex.org/I4210118383"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Alexander M. Menzies","raw_affiliation_strings":["Disciplines of Medicine, Sydney Medical School, The University of Sydney, Sydney, NSW Australia","Melanoma Institute Australia, Sydney, NSW, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Disciplines of Medicine, Sydney Medical School, The University of Sydney, Sydney, NSW Australia","institution_ids":["https://openalex.org/I129604602"]},{"raw_affiliation_string":"Melanoma Institute Australia, Sydney, NSW, Australia","institution_ids":["https://openalex.org/I4210118383"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022245495","display_name":"Bernadette Pedersen","orcid":"https://orcid.org/0000-0002-9278-5663","observed_orcids":["https://orcid.org/0000-0002-9278-5663"]},"institutions":[{"id":"https://openalex.org/I129604602","display_name":"The University of Sydney","ror":"https://ror.org/0384j8v12","country_code":"AU","type":"education","lineage":["https://openalex.org/I129604602"]},{"id":"https://openalex.org/I2803024705","display_name":"Westmead Hospital","ror":"https://ror.org/04gp5yv64","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I2803024705","https://openalex.org/I4405259172"]},{"id":"https://openalex.org/I4210118383","display_name":"Melanoma Institute Australia","ror":"https://ror.org/02jxrhq31","country_code":"AU","type":"nonprofit","lineage":["https://openalex.org/I4210118383"]},{"id":"https://openalex.org/I4210145422","display_name":"Westmead Institute for Medical Research","ror":"https://ror.org/04zj3ra44","country_code":"AU","type":"facility","lineage":["https://openalex.org/I4210145422"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Bernadette Pedersen","raw_affiliation_strings":["Centre for Cancer Research, The Westmead Millennium Institute for Medical Research, University of Sydney, Westmead Hospital, Westmead, NSW, Australia","Melanoma Institute Australia, Sydney, NSW Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre for Cancer Research, The Westmead Millennium Institute for Medical Research, University of Sydney, Westmead Hospital, Westmead, NSW, Australia","institution_ids":["https://openalex.org/I129604602","https://openalex.org/I2803024705","https://openalex.org/I4210145422"]},{"raw_affiliation_string":"Melanoma Institute Australia, Sydney, NSW Australia","institution_ids":["https://openalex.org/I4210118383"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066064493","display_name":"Peter A. Johansson","orcid":"https://orcid.org/0000-0001-7015-5452","observed_orcids":["https://orcid.org/0000-0001-7015-5452"]},"institutions":[{"id":"https://openalex.org/I217937681","display_name":"QIMR Berghofer Medical Research Institute","ror":"https://ror.org/004y8wk30","country_code":"AU","type":"facility","lineage":["https://openalex.org/I217937681"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Peter Johansson","raw_affiliation_strings":["Oncogenomics Laboratory, QIMR Berghofer Medical Research Institute, Herston, Brisbane, QLD, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oncogenomics Laboratory, QIMR Berghofer Medical Research Institute, Herston, Brisbane, QLD, Australia","institution_ids":["https://openalex.org/I217937681"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052284583","display_name":"Nicholas K. Hayward","orcid":"https://orcid.org/0000-0003-4760-1033","observed_orcids":["https://orcid.org/0000-0003-4760-1033"]},"institutions":[{"id":"https://openalex.org/I217937681","display_name":"QIMR Berghofer Medical Research Institute","ror":"https://ror.org/004y8wk30","country_code":"AU","type":"facility","lineage":["https://openalex.org/I217937681"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Nicholas K. Hayward","raw_affiliation_strings":["Oncogenomics Laboratory, QIMR Berghofer Medical Research Institute, Herston, Brisbane, QLD, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oncogenomics Laboratory, QIMR Berghofer Medical Research Institute, Herston, Brisbane, QLD, Australia","institution_ids":["https://openalex.org/I217937681"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062978331","display_name":"Richard F. Kefford","orcid":"https://orcid.org/0000-0001-9251-9229","observed_orcids":["https://orcid.org/0000-0001-9251-9229"]},"institutions":[{"id":"https://openalex.org/I129604602","display_name":"The University of Sydney","ror":"https://ror.org/0384j8v12","country_code":"AU","type":"education","lineage":["https://openalex.org/I129604602"]},{"id":"https://openalex.org/I2803024705","display_name":"Westmead Hospital","ror":"https://ror.org/04gp5yv64","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I2803024705","https://openalex.org/I4405259172"]},{"id":"https://openalex.org/I4210118383","display_name":"Melanoma Institute Australia","ror":"https://ror.org/02jxrhq31","country_code":"AU","type":"nonprofit","lineage":["https://openalex.org/I4210118383"]},{"id":"https://openalex.org/I4210145422","display_name":"Westmead Institute for Medical Research","ror":"https://ror.org/04zj3ra44","country_code":"AU","type":"facility","lineage":["https://openalex.org/I4210145422"]},{"id":"https://openalex.org/I99043593","display_name":"Macquarie University","ror":"https://ror.org/01sf06y89","country_code":"AU","type":"education","lineage":["https://openalex.org/I99043593"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Richard F. Kefford","raw_affiliation_strings":["Centre for Cancer Research, The Westmead Millennium Institute for Medical Research, University of Sydney, Westmead Hospital, Westmead, NSW Australia","Disciplines of Medicine, Sydney Medical School, The University of Sydney, Sydney, NSW Australia","Faculty of Medicine and Health Sciences, Macquarie University, Sydney, NSW, Australia","Melanoma Institute Australia, Sydney, NSW Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre for Cancer Research, The Westmead Millennium Institute for Medical Research, University of Sydney, Westmead Hospital, Westmead, NSW Australia","institution_ids":["https://openalex.org/I129604602","https://openalex.org/I2803024705","https://openalex.org/I4210145422"]},{"raw_affiliation_string":"Disciplines of Medicine, Sydney Medical School, The University of Sydney, Sydney, NSW Australia","institution_ids":["https://openalex.org/I129604602"]},{"raw_affiliation_string":"Faculty of Medicine and Health Sciences, Macquarie University, Sydney, NSW, Australia","institution_ids":["https://openalex.org/I99043593"]},{"raw_affiliation_string":"Melanoma Institute Australia, Sydney, NSW Australia","institution_ids":["https://openalex.org/I4210118383"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083653505","display_name":"Richard A. Scolyer","orcid":"https://orcid.org/0000-0002-8991-0013","observed_orcids":["https://orcid.org/0000-0002-8991-0013"]},"institutions":[{"id":"https://openalex.org/I129604602","display_name":"The University of Sydney","ror":"https://ror.org/0384j8v12","country_code":"AU","type":"education","lineage":["https://openalex.org/I129604602"]},{"id":"https://openalex.org/I2799732068","display_name":"Royal Prince Alfred Hospital","ror":"https://ror.org/05gpvde20","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I2799732068"]},{"id":"https://openalex.org/I4210118383","display_name":"Melanoma Institute Australia","ror":"https://ror.org/02jxrhq31","country_code":"AU","type":"nonprofit","lineage":["https://openalex.org/I4210118383"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Richard A. Scolyer","raw_affiliation_strings":["Departments of Tissue Pathology and Diagnostic Oncology Royal Prince Alfred Hospital, Camperdown, NSW Australia","Disciplines of Pathology, Sydney Medical School, The University of Sydney, Sydney, NSW Australia","Melanoma Institute Australia, Sydney, NSW, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of Tissue Pathology and Diagnostic Oncology Royal Prince Alfred Hospital, Camperdown, NSW Australia","institution_ids":["https://openalex.org/I2799732068"]},{"raw_affiliation_string":"Disciplines of Pathology, Sydney Medical School, The University of Sydney, Sydney, NSW Australia","institution_ids":["https://openalex.org/I129604602"]},{"raw_affiliation_string":"Melanoma Institute Australia, Sydney, NSW, Australia","institution_ids":["https://openalex.org/I4210118383"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070576000","display_name":"Georgina Venetia Long","orcid":"https://orcid.org/0000-0001-8894-3545","observed_orcids":["https://orcid.org/0000-0001-8894-3545"]},"institutions":[{"id":"https://openalex.org/I129604602","display_name":"The University of Sydney","ror":"https://ror.org/0384j8v12","country_code":"AU","type":"education","lineage":["https://openalex.org/I129604602"]},{"id":"https://openalex.org/I4210118383","display_name":"Melanoma Institute Australia","ror":"https://ror.org/02jxrhq31","country_code":"AU","type":"nonprofit","lineage":["https://openalex.org/I4210118383"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Georgina V. Long","raw_affiliation_strings":["Disciplines of Medicine, Sydney Medical School, The University of Sydney, Sydney, NSW Australia","Melanoma Institute Australia, Sydney, NSW, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Disciplines of Medicine, Sydney Medical School, The University of Sydney, Sydney, NSW Australia","institution_ids":["https://openalex.org/I129604602"]},{"raw_affiliation_string":"Melanoma Institute Australia, Sydney, NSW, Australia","institution_ids":["https://openalex.org/I4210118383"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5069277796","display_name":"Helen Rizos","orcid":"https://orcid.org/0000-0002-2094-9198","observed_orcids":["https://orcid.org/0000-0002-2094-9198"]},"institutions":[{"id":"https://openalex.org/I4210118383","display_name":"Melanoma Institute Australia","ror":"https://ror.org/02jxrhq31","country_code":"AU","type":"nonprofit","lineage":["https://openalex.org/I4210118383"]},{"id":"https://openalex.org/I99043593","display_name":"Macquarie University","ror":"https://ror.org/01sf06y89","country_code":"AU","type":"education","lineage":["https://openalex.org/I99043593"]}],"countries":["AU"],"is_corresponding":true,"raw_author_name":"Helen Rizos","raw_affiliation_strings":["Faculty of Medicine and Health Sciences, Macquarie University, Sydney, NSW, Australia","Melanoma Institute Australia, Sydney, NSW Australia"],"raw_orcid":"https://orcid.org/0000-0002-2094-9198","affiliations":[{"raw_affiliation_string":"Faculty of Medicine and Health Sciences, Macquarie University, Sydney, NSW, Australia","institution_ids":["https://openalex.org/I99043593"]},{"raw_affiliation_string":"Melanoma Institute Australia, Sydney, NSW Australia","institution_ids":["https://openalex.org/I4210118383"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":7,"corresponding_author_ids":["https://openalex.org/A5069277796"],"corresponding_institution_ids":["https://openalex.org/I4210118383","https://openalex.org/I99043593"],"apc_list":{"value":3890,"currency":"USD","value_usd":3890},"apc_paid":{"value":3890,"currency":"USD","value_usd":3890},"fwci":0.9271,"has_fulltext":true,"cited_by_count":25,"citation_normalized_percentile":{"value":0.69698864,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":98},"biblio":{"volume":"5","issue":"1","first_page":"17","last_page":"17"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11533","display_name":"Melanoma and MAPK Pathways","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11533","display_name":"Melanoma and MAPK Pathways","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10604","display_name":"RNA Research and Splicing","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/melanoma","display_name":"melanoma","score":0.8410000205039978},{"id":"https://openalex.org/keywords/braf-inhibitors","display_name":"BRAF inhibitors","score":0.9269999861717224},{"id":"https://openalex.org/keywords/acquired-drug-resistance","display_name":"acquired drug resistance","score":0.9470000267028809},{"id":"https://openalex.org/keywords/alternative-splicing","display_name":"alternative splicing","score":0.8230000138282776},{"id":"https://openalex.org/keywords/intronic-variants","display_name":"intronic variants","score":0.6330000162124634},{"id":"https://openalex.org/keywords/mek-inhibitors","display_name":"MEK inhibitors","score":0.9300000071525574}],"concepts":[{"id":"https://openalex.org/C36823959","wikidata":"https://www.wikidata.org/wiki/Q373027","display_name":"Exon","level":3,"score":0.8618982434272766},{"id":"https://openalex.org/C54458228","wikidata":"https://www.wikidata.org/wiki/Q237218","display_name":"RNA splicing","level":4,"score":0.8390146493911743},{"id":"https://openalex.org/C176944494","wikidata":"https://www.wikidata.org/wiki/Q1415380","display_name":"Point mutation","level":4,"score":0.726487398147583},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5915414094924927},{"id":"https://openalex.org/C501734568","wikidata":"https://www.wikidata.org/wiki/Q42918","display_name":"Mutation","level":3,"score":0.5765519738197327},{"id":"https://openalex.org/C94671646","wikidata":"https://www.wikidata.org/wiki/Q207551","display_name":"Intron","level":3,"score":0.5180901885032654},{"id":"https://openalex.org/C2777658100","wikidata":"https://www.wikidata.org/wiki/Q180614","display_name":"Melanoma","level":2,"score":0.5019738674163818},{"id":"https://openalex.org/C194583182","wikidata":"https://www.wikidata.org/wiki/Q21114084","display_name":"Alternative splicing","level":4,"score":0.45817941427230835},{"id":"https://openalex.org/C2776131300","wikidata":"https://www.wikidata.org/wiki/Q423111","display_name":"Vemurafenib","level":4,"score":0.45132556557655334},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.40966564416885376},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.40225017070770264},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.33346444368362427},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.3039637804031372},{"id":"https://openalex.org/C67705224","wikidata":"https://www.wikidata.org/wiki/Q11053","display_name":"RNA","level":3,"score":0.23495888710021973},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.2026277482509613},{"id":"https://openalex.org/C2994587330","wikidata":"https://www.wikidata.org/wiki/Q180614","display_name":"Metastatic melanoma","level":3,"score":0.06069415807723999}],"mesh":[],"locations_count":6,"locations":[{"id":"doi:10.1186/s40364-017-0098-3","doi":"https://doi.org/10.1186/s40364-017-0098-3","is_oa":true,"landing_page_url":"https://doi.org/10.1186/s40364-017-0098-3","pdf_url":"https://link.springer.com/content/pdf/10.1186/s40364-017-0098-3.pdf","source":{"id":"https://openalex.org/S2764853569","display_name":"Biomarker Research","issn_l":"2050-7771","issn":["2050-7771"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","doyens","jufo-1","ki-jl-1","norway-1","oarl","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Biomarker Research","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:4276196","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/5426037","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmh:oai:https://researchers.mq.edu.au:publications/9013ac4a-5f4f-4fbf-b9dc-429cab1b9cb1","doi":null,"is_oa":true,"landing_page_url":"https://researchers.mq.edu.au/en/publications/9013ac4a-5f4f-4fbf-b9dc-429cab1b9cb1","pdf_url":null,"source":{"id":"https://openalex.org/S7407050580","display_name":"Macquarie University","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I99043593","host_organization_name":"Macquarie University","host_organization_lineage":["https://openalex.org/I99043593"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pupo, G M, Boyd, S C, Fung, C, Carlino, M S, Menzies, A M, Pedersen, B, Johansson, P, Hayward, N K, Kefford, R F, Scolyer, R A, Long, G V & Rizos, H 2017, 'Clinical significance of intronic variants in BRAF inhibitor resistant melanomas with altered BRAF transcript splicing', Biomarker Research, vol. 5, no. 1, 17, pp. 1-4. https://doi.org/10.1186/s40364-017-0098-3","raw_type":"info:eu-repo/semantics/article"},{"id":"pmid:28503307","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/28503307","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Biomarker research","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:5426037","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC5426037/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Biomark Res","raw_type":"Text"},{"id":"pmh:oai:doaj.org/article:84e147d5245d4efc8c430efe2b83f592","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/84e147d5245d4efc8c430efe2b83f592","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Biomarker Research, Vol 5, Iss 1, Pp 1-4 (2017)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1186/s40364-017-0098-3","doi":"https://doi.org/10.1186/s40364-017-0098-3","is_oa":true,"landing_page_url":"https://doi.org/10.1186/s40364-017-0098-3","pdf_url":"https://link.springer.com/content/pdf/10.1186/s40364-017-0098-3.pdf","source":{"id":"https://openalex.org/S2764853569","display_name":"Biomarker Research","issn_l":"2050-7771","issn":["2050-7771"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","doyens","jufo-1","ki-jl-1","norway-1","oarl","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Biomarker Research","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9391000270843506}],"study_designs":[],"awards":[{"id":"https://openalex.org/G3822618223","display_name":"Molecular determinants of risk, progression and treatment response in melanoma","funder_award_id":"1093017","funder_id":"https://openalex.org/F4320334705","funder_display_name":"National Health and Medical Research Council"},{"id":"https://openalex.org/G5560813891","display_name":"Molecular determinants of risk, progression and treatement response in melenoma","funder_award_id":"633004","funder_id":"https://openalex.org/F4320334705","funder_display_name":"National Health and Medical Research Council"},{"id":"https://openalex.org/G7866663527","display_name":"Melanoma resistance to combination BRAF and MEK inhibition is driven by reprogramming of MAPK signaling","funder_award_id":"1066735","funder_id":"https://openalex.org/F4320334705","funder_display_name":"National Health and Medical Research Council"}],"funders":[{"id":"https://openalex.org/F4320329041","display_name":"Melanoma Institute Australia","ror":"https://ror.org/02jxrhq31"},{"id":"https://openalex.org/F4320334626","display_name":"Medical Research Council","ror":"https://ror.org/03x94j517"},{"id":"https://openalex.org/F4320334705","display_name":"National Health and Medical Research Council","ror":"https://ror.org/011kf5r70"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2613601474.pdf","grobid_xml":"https://content.openalex.org/works/W2613601474.grobid-xml"},"referenced_works_count":12,"referenced_works":["https://openalex.org/W1990511191","https://openalex.org/W2003402062","https://openalex.org/W2043058822","https://openalex.org/W2079699077","https://openalex.org/W2081895491","https://openalex.org/W2105660237","https://openalex.org/W2116978375","https://openalex.org/W2128542677","https://openalex.org/W2132123037","https://openalex.org/W2166262263","https://openalex.org/W2176310149","https://openalex.org/W2253174922"],"related_works":["https://openalex.org/W2203233036","https://openalex.org/W7097238630","https://openalex.org/W2033500310","https://openalex.org/W2142913791","https://openalex.org/W7053027404","https://openalex.org/W4253801673","https://openalex.org/W2253174922","https://openalex.org/W4285731868","https://openalex.org/W2956010168"],"abstract_inverted_index":{"Alternate":[0],"BRAF":[1,12,19,35,75,78,98],"splicing":[2,22,41,81,99],"is":[3,82],"the":[4],"most":[5],"common":[6],"mechanism":[7],"of":[8,34],"acquired":[9,72],"resistance":[10,73],"to":[11,25,74,104],"inhibitor":[13],"treatment":[14],"in":[15,49,59,65],"melanoma.":[16],"Recently,":[17],"alternate":[18,77],"exon":[20,36,79],"4\u20138":[21,80],"was":[23,47],"shown":[24],"involve":[26],"an":[27],"intronic":[28,45,87],"mutation,":[29],"located":[30],"51":[31],"nucleotides":[32],"upstream":[33],"9":[37],"within":[38],"a":[39,50],"predicted":[40],"branch":[42,88],"point.":[43],"This":[44],"mutation":[46],"identified":[48],"single":[51],"cell":[52],"line":[53],"but":[54],"has":[55],"not":[56,83],"been":[57],"examined":[58],"vivo.":[60],"Herein":[61],"we":[62],"demonstrate":[63],"that":[64,94],"three":[66],"melanomas":[67],"biopsied":[68],"from":[69],"patients":[70],"with":[71,85],"inhibitors,":[76],"associated":[84],"this":[86],"point":[89],"mutation.":[90],"We":[91],"also":[92],"confirm":[93],"melanoma":[95],"cells":[96],"expressing":[97],"variants":[100],"retain":[101],"exquisite":[102],"sensitivity":[103],"existing":[105],"FDA-approved":[106],"MEK":[107],"inhibitors.":[108]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2613601474","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2024,"cited_by_count":4},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":6},{"year":2020,"cited_by_count":6},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":3}],"updated_date":"2026-11-17T12:49:18.490984","created_date":"2017-05-19T00:00:00"}
